Anti‐platelet factor 4 immunothrombotic syndromes
Open Access
- 26 July 2024
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 205 (4) , 1291-1295
Abstract
Anti‐platelet factor 4 immunothrombotic syndromes comprise a group of disorders that include heparin‐induced thrombocytopenia and vaccine‐induced immune thrombocytopenia and thrombosis. These are highly prothrombotic, immunological disorders characterised by specific clinical and pathological criteria which include thrombocytopenia and thrombosis. While they are predominantly triggered by heparin and the adenoviral vector vaccines, respectively, other provoking factors have been described, as well as spontaneous forms. The unexplained co‐occurrence of thrombocytopenia with thrombosis should raise suspicion and prompt testing. This nutshell review discusses the pathophysiology, presenting features and diagnostic criteria for these conditions.Keywords
This publication has 22 references indexed in Scilit:
- Diagnosis and management of heparin‐induced thrombocytopenia: Third editionBritish Journal of Haematology, 2023
- Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like AntibodiesNew England Journal of Medicine, 2023
- Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopeniaJournal of Thrombosis and Haemostasis, 2023
- Platelet factor 4 triggers thrombo‐inflammation by bridging innate and adaptive immunityInternational Journal of Laboratory Hematology, 2023
- Anti‐platelet factor 4 immunoglobulin G levels in vaccine‐induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 monthsResearch and Practice in Thrombosis and Haemostasis, 2022
- Clinical Features of Vaccine-Induced Immune Thrombocytopenia and ThrombosisNew England Journal of Medicine, 2021
- Frequency and Clinical Impact of Platelet Factor 4-Specific Antibodies in Patients Undergoing Extracorporeal Membrane OxygenationThrombosis and Haemostasis, 2019
- Prevalence of Heparin/Platelet Factor 4 Antibodies Before and After Cardiac SurgeryThe Annals of Thoracic Surgery, 2007
- Crystal Structure of Recombinant Human Platelet Factor 4Biochemistry, 1994
- Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with plateletsBritish Journal of Haematology, 1989